Gryphon Therapeutics
9Patents
0Active
9Granted
29Portfolio score
Filing activity: May 12, 1994 → Nov 15, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6552167B1 | Polyamide chains of precise length | Chemistry; Metallurgy | 100 | Expired |
| US6844161B2 | Modular protein libraries and methods of preparation | Human Necessities | 41 | Expired |
| US6673347B1 | Polypeptide and protein derivatives and process for their preparation | Human Necessities | 13 | Expired |
| US6663869B1 | Polyoxime compounds and their preparation | Human Necessities | 4 | Expired |
| US6977292B2 | Nucleophile-stable thioester generating compounds, methods of production and use | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7030217B2 | Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution | Chemistry; Metallurgy | 1 | Expired |
| US7094871B2 | Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution | Chemistry; Metallurgy | 0 | Expired |
| US6942852B1 | N-terminal modifications of RANTES and methods of use | Human Necessities | 0 | Expired |
| US7030218B2 | Pseudo native chemical ligation | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.